Skip to main content
Fig. 3 | Hereditas

Fig. 3

From: Identification of glioblastoma immune subtypes and immune landscape based on a large cohort

Fig. 3

A The distribution difference of classical markers expression in chemotherapy-induced immune response in the TCGA-GBM Agilent. B The distribution difference of classical markers expression in chemotherapy-induced immune response in the TCGA-GBM HiSeq. C The distribution difference of immune checkpoint genes in the TCGA-GBM Agilent. D The distribution difference of immune checkpoint genes in the TCGA-GBM HiSeq. Significance was calculated using analysis of variance (* < 0.05; ** < 0.01; *** < 0.001; **** < 0.0001)

Back to article page